Menstrual Cycle Maintenance and Quality of Life After Breast Cancer Treatment: A Prospective Study.

Abstract

About 15% of the 186,000 estimated annual cases of breast cancer this year will occur in women of childbearing age. Most will undergo adjuvant chemotherapy and almost half will suffer therapy-induced menopause. Even without desire for childbearing, the quality of life of these young patients may be compromised by premature menopause with symptoms such as hot flashes, sleep disturbances, decreased libido, and vagina dryness. Very little is known about the incidence, onset, time course, and symptomatology of premature menopause induced by breast cancer therapy and virtually nothing is known about its impact on the young survivor's quality of life. No prospective study heretofore exists. A comprehensive analysis on a large prospective study cohort as proposed herein will elucidate determinants of premature menopause. Now unavailable, such * an individual risk profile of premature menopause could be critical to the clinician and to the young patient in considering options and decision-making about chemotherapy.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 1997
Accession Number
ADA340744

Entities

People

  • Jeanne Petrek

Organizations

  • Memorial Sloan Kettering Cancer Center

Tags

DTIC Thesaurus Topics

  • Breast Cancer
  • Chemotherapy
  • Data Analysis
  • Data Science
  • Databases
  • Drug Therapy
  • Health Services
  • Information Science
  • Institutional Review Board
  • Medical Personnel
  • Menstrual Cycle
  • Neoplasms
  • Organizational Structure
  • Physicians
  • Quality Of Life
  • Surveys
  • Therapy

Fields of Study

  • Medicine

Readers

  • Oncology
  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.